1
Clinical Trials associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)A Randomized, Parallel-group, Multi-Center, Assessor-blind Phase 3 Study to Compare the Efficacy, Safety and Ease of Use of Two Follicle Stimulating Hormone -Human Recombinant (r-hFSH) 900 IU (66.0 µg) / 1.5mL Solution for Injection in Prefilled Pen (Foligraf®- Manufactured by BSV and Gonal-f® Manufactured by Merck Serono) in Subjects Undergoing Controlled Ovarian Stimulation for Assisted Reproductive Technology - REFRESH
100 Clinical Results associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)
100 Translational Medicine associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)
100 Patents (Medical) associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)
100 Deals associated with Follicle stimulating hormone biosimilar(Bharat Serums & Vaccines Ltd.)